Department of Medicine I, Klinik Landstraße, Vienna, Austria.
Karl Landsteiner Institute for Obesity and Metabolic Disorders, Vienna, Austria.
Obes Facts. 2021;14(5):510-519. doi: 10.1159/000517766. Epub 2021 Sep 8.
Cortisol is involved in the regulation of gluconeogenesis and glucose utilization. In morbid obesity (MO), the association of cortisol excretion with metabolic parameters is not well-characterized. In our study, we evaluated cortisol excretion in nondiabetic subjects with MO and its effect on glucose metabolism.
We included 1,249 nondiabetic patients with MO (79.8% females, mean BMI 44.9 ± 6.5 kg/m2, mean age 38 ± 11 years). Anthropometric data and cardiovascular risk factors were assessed, and an oral glucose tolerance test for calculation of insulin resistance was performed. Cortisol excretion was assessed on 2 consecutive days (24 h urine specimens).
Regarding cortisol excretion, patients were divided into 3 tertiles (urinary cortisol ≤51.6, >51.6 and <117.6, and ≥117.6 μg/24 h, respectively). Patients in the highest tertile were younger (p = 0.003), more obese (BMI: p = 0.040), had lower diastolic blood pressure ([DBP]; p = 0.012), lower total (p = 0.032) and LDL cholesterol (p = 0.021), fasting (p = 0.049) and 2-h glycemia (p = 0.028), 2-h insulinemia (p = 0.020), and HbA1c (p < 0.001), and a higher estimated glomerular filtration rate (eGFR) (p < 0.001). The glucose (p < 0.001) and insulin (p = 0.011) area under the curve (AUC) were also lower. Urinary cortisol excretion adjusted for age, sex, and eGFR was positively correlated with body weight (BW, beta = 0.076, p = 0.004) and overall glucose tolerance (oral disposition index, beta = 0.090, p = 0.011), and negatively with HbA1c (beta = -0.179, p < 0.001), 2-h glycemia (beta = -0.075, p = 0.032), AUC glucose (beta = -0.103, p = 0.002), and DBP (beta = -0.139, p < 0.001). HbA1c, BW, and DBP remained significant after multivariable analysis.
DISCUSSION/CONCLUSION: Despite being more obese, patients with higher cortisol excretion have a more favorable metabolic profile. These results deserve further attention regarding the respective mechanisms.
皮质醇参与葡萄糖生成和葡萄糖利用的调节。在病态肥胖(MO)中,皮质醇排泄与代谢参数的关系尚未得到很好的描述。在我们的研究中,我们评估了 MO 中非糖尿病患者的皮质醇排泄情况及其对葡萄糖代谢的影响。
我们纳入了 1249 名非糖尿病 MO 患者(79.8%为女性,平均 BMI 为 44.9±6.5kg/m2,平均年龄为 38±11 岁)。评估了患者的人体测量数据和心血管危险因素,并进行了口服葡萄糖耐量试验以计算胰岛素抵抗。皮质醇排泄在连续 2 天(24 小时尿标本)进行评估。
根据皮质醇排泄情况,患者被分为 3 个三分位数(尿皮质醇≤51.6、>51.6 和<117.6、≥117.6μg/24h)。处于最高三分位的患者更年轻(p=0.003),更肥胖(BMI:p=0.040),舒张压(DBP;p=0.012)更低,总胆固醇(p=0.032)和 LDL 胆固醇(p=0.021)、空腹(p=0.049)和 2 小时血糖(p=0.028)、2 小时胰岛素(p=0.020)和 HbA1c(p<0.001)水平更低,肾小球滤过率估计值(eGFR)更高(p<0.001)。血糖(p<0.001)和胰岛素(p=0.011)的曲线下面积(AUC)也较低。经年龄、性别和 eGFR 校正的尿皮质醇排泄与体重(BW,β=0.076,p=0.004)和总体葡萄糖耐量(口服处置指数,β=0.090,p=0.011)呈正相关,与 HbA1c(β=-0.179,p<0.001)、2 小时血糖(β=-0.075,p=0.032)、AUC 葡萄糖(β=-0.103,p=0.002)和 DBP(β=-0.139,p<0.001)呈负相关。多变量分析后,HbA1c、BW 和 DBP 仍然具有统计学意义。
讨论/结论:尽管更肥胖,皮质醇排泄较高的患者具有更有利的代谢特征。这些结果值得进一步关注各自的机制。